Health Research Colloquium Calls On Countries To Invest More In R&D 09/04/2013 by Intellectual Property Watch 1 Comment During the recent Council on Health Research for Development (COHRED) Colloquium 2013, participants highlighted the value of research and development in supporting public health and the importance of building self-reliance for countries through government investment, according to organisers. Some of the themes discussed during the event will be included in a report on public health policy, which will be published in The Lancet later this year.
WIPO Hails India’s Accession To Trademark System; India Advocates Balance 09/04/2013 by Catherine Saez, Intellectual Property Watch 1 Comment A full room of country delegates and ambassadors gathered yesterday to celebrate the accession of India to the Madrid Protocol for the International Registration of Marks at the World Intellectual Property Organization. However, beyond the joy of accession, the recent decision of the Indian Supreme Court on a Novartis drug patent loomed in the room.
North American Universities Seen Failing To Promote Socially Responsible Licensing 05/04/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment A student group is holding top research universities in the US and Canada accountable for how much they are – or are not – contributing to global public health. According to a recently released report by Universities Allied for Essential Medicines, a non-profit organisation, most institutions are falling short when it comes to investing in neglected diseases and promoting access to medicines.
The Judgment In Novartis v. India: What The Supreme Court Of India Said 04/04/2013 by Intellectual Property Watch 9 Comments Following the Indian Supreme Court decision in Novartis AG v. Union of India, Prof. Frederick Abbott says, “the judgment is well-crafted, with close attention to the facts presented, and appears to take a balanced view of the matters brought before the Court.”
Linguistic Diversity Essential For Innovation, Development, Roundtable Speakers Say 04/04/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment Multilingualism not only expands cultural horizons but also provides a tool for innovation, speakers gathered at an international roundtable yesterday said. However, language uniformity is a tempting road taken by many – often for cost-related reasons – while multilingualism should be promoted as a factor in development, they said.
Australian Pharmaceutical Patents Review Draft Report Critical Of Patent Extensions, R&D Funding 03/04/2013 by Kelly Burke for Intellectual Property Watch Leave a Comment The Australian Pharmaceutical Patents Review yesterday issued its draft report, recommending that the Australian government reduce pharmaceutical patent extension terms and use estimated savings to subsidise research and development.
Obama Announces Multi-Million Dollar Research Initiative To Study Human Brain 02/04/2013 by Kelly Burke for Intellectual Property Watch Leave a Comment US President Obama today announced a broad new research initiative to map, explore, and better understand the human brain while finding ways to treat brain-related diseases.
Novartis Loses Patent Bid: Lessons From India’s 3(d) Experience 01/04/2013 by Patralekha Chatterjee for Intellectual Property Watch 15 Comments New Delhi – On 1 April, in a packed room in India’s Supreme Court, two judges – Justice Aftab Alam and Justice Ranjana Desai – delivered a verdict that has the potential to dramatically change the national and global conversation about patents and patients.
Singapore Reveals 10-Year Plan To Be Global IP Hub 01/04/2013 by Intellectual Property Watch Leave a Comment The Government of Singapore today has revealed a set of initiatives it plans to implement over the next decade to further develop the country as an intellectual property hub.
East African Community Doubles Efforts To Boost Local Pharmaceutical Production 28/03/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment Arusha, Tanzania – Pharmaceutical manufacturers in East Africa have joined forces to strengthen their production capacity to meet at least half of the region’s demand for affordable, quality medicines. The East African Community is supporting this ambitious goal through various initiatives, including a regional intellectual property policy to guide partner states on developing national legislation that fosters local pharmaceutical production.